Is there a correlation between the release of interleukin-12 and the clinical outcome of polytrauma patients?;Korreliert die Freisetzung von Interleukin-12 mit dem klinischen Verlauf des polytraumatisierten Patienten?

Chirurg

Volumn 71, Issue 9, 2000, Pages 1126-1131

  Wick, M ^a,b   Kollig, E ^a   Walz, M ^a   Muhr, G ^a   Koller M ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Immune regulation; Interleukin 12; Polytrauma; Thoraxtrauma

Indexed keywords

INTERLEUKIN 12;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; INJURY SCALE; INTENSIVE CARE; MALE; MIDDLE AGED; MORTALITY; MULTIPLE ORGAN FAILURE; MULTIPLE TRAUMA; PROGNOSIS; REFERENCE VALUE; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; INJURY SEVERITY SCORE; INTENSIVE CARE; INTERLEUKIN-12; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; MULTIPLE TRAUMA; PROGNOSIS; REFERENCE VALUES; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0034263182     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001040051189     Document Type: Article

References (29)

1. Antonelli M, Moro ML, Capelli O, De Blasi RA, et al (1994) Risk factors for early onset pneumonia in trauma patients. Chest 105: 224
2. Baker SP, O,Neill B, Haddon W, Long WB (1974) The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma 14: 187
3. Bone RC, Balk RA, Cerra FB, Dellinger RP, et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644
4. Browder W, Chuanfu L, Kalbfleisch JH, Ferguson DA Jr, Williams DL (1999) Early activation of pulmonary factor kappaB and nuclear factor interleukin-6 in polymicrobial sepsis. J Trauma 46: 590
5. Brunda MJ (1994) Interleukin-12. J Leukoc Biol 55: 280
6. Car BD, Eng VM, Schnyder B, LeHir M, et al (1995) Role of interferon-gamma in interleukin 12-induced pathology in mice. Am J Pathol 147: 1693
7. Eidelman LA, Pizov R, Sprung CL (1995) New therapeutic approaches in sepsis: a critical review. Intensive Care Med 21 Suppl. 2: 269
8. Ertel W, Keel M, Bonaccio M, Steckholzer U, et al (1995) Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome. J Trauma 39: 879
9. Ertel W, Keel M, Neidhardt R, Steckholzer U, et al (1997) Inhibition of the defense system stimulating interleukin-12 interferon-gamma pathway during critical illness. Blood 89: 1612
10. Goris JA, Boeckhorst TPA te, Nuytinck JKS, Wimbere JSF (1985) Multiple organ failure. Generalized autodestructive inflammation. Arch Surg 120: 1109
11. Greenberger MJ, Kunkel SL, Stricter RM, Lucas NW, et al (1996) IL-12 therapy protects mice in lethal Klebsiella pneumonia. J Immunol 157: 3006
12. Greenspan L, McLellan B, Greig H (1985) Abbreviated injury scale and injury severity score: a scoring chart. J Trauma 25: 60
13. Hauser CJ, Zhou X, Joshi P, Cuchens MA, et al (1997) The immune microenvironment of human fracture/soft-tissue hematomas and ist relationship to systemic immunity. J Trauma 42: 895
14. Hensler T, Heidecke CD, Hecker H, Heeg K, et al (1997) Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production. J Immunol 161: 2655
15. Keene AR, Cullen DJ (1983) Therapeutic intervention scoring system: update 1983. Crit Care Med 11: 1
16. Köller M, David A, Hahn MP, Muhr G (1998) Freisetzung von Interleukin-12 (IL-12) nach Trauma und Polytrauma. Langenbecks Arch Surg (Forumband) 383: 453
17. Larsen R (1994) SIRS-Systemic Inflammatory Response Syndrome. Anästhesiol Intensivmed Notfallmed Schmerzther 29: 36
18. Nast-Kolb D, Waydhas C, Gippner-Steppert C, Schneider I, et al (1997) Indicators of the posttraumatic Inflammatory response correlate with organ failure in patients with multiple injuries. J Trauma 42: 446
19. Neidhardt R, Keel M, Steckholzer U, Safret A, et al (1997) Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 42: 863
20. Romani L, Puccetti P, Bistoni F (1997) Interleukin-12 in infectious diseases. Clin Microbiol Rev 10: 611
21. Ryffel B (1997) Interleukin-12: role of interferon-gamma in IL-12 adverse effects. Clin Immunol Immunopathol 83: 18
22. Schlag G, Redl H, Bahrami S (1994) SIRS nach Trauma und bei Sepsis. Anästhesiol Intensivmed Notfallmed Schmerzther 29: 37
23. Smail N, Messiah A, Edouard A, Descorps-Declère A, et al (1995) Role of systemic inflammatory response syndrome and infection in the occurence of early multiple organ dysfunction syndrome following severe trauma. Intensive Care Med 21: 813
24. Stahel PF, Kossmann T, Joller H, Trentz O, Morganti-Kossmann MC (1998) Increased interleukin-12 levels in human cerebrospinal fluid following severehead trauma. Neurosci Lett 249: 123
25. The ACCP/SCCM Consensus Conference Committee (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 101: 1644
26. Trinchieri G, Gerosa F (1996) Immunoregulation by interleukin-12. Leukoc Biol 59: 505
27. Wick M, Ekkernkamp A, Muhr G (1997) Epidemiologie des Polytraumas. Chirurg 68: 1053
28. Zhang M, Gately MK, Wang E, Gong J, et al (1994) Interleukin 12 at the site of disease in tuberculosis. J Clin Invest 93: 1733
29. Zisman DA, Kunkel SL, Strieter RM, Gauldie J, et al (1997) Anti-interleukin-12 therapy protects mice in lethal endotoxemia but impairs bacterial clearance in murine Escherichia coli peritoneal sepsis. Shock 8: 349